Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Busha AI: N-acetyl cysteine as a glutathione precursor for schizophreniaa double-blind, randomized, placebo-controlled trial
Verschillende studies hebben aangetoond dat medicatie voor obesitas en bariatrische chirurgie zeer effectieve en duurzame effecten op het gewicht induceren ten opzichte van leefstijlinterventies alleen
Commercial insurance : Most major insurers now cover FDA-approved GLP-1 weight-loss medications (Wegovy, Saxenda, Zepbound) with prior authorization
Side effects can be managed through dietary modifications (smaller meals, avoiding high-fat foods), adherence to dose escalation schedules, and appropriate hydration
The key structural modification is a C18 fatty diacid chain attached at position 26 (lysine) via a linker, which enables non-covalent binding to albumin in the bloodstream